VECTALYS

vectalys-logo

Vectalys, expert in gene delivery based on lentiviral vectors, is a private biotech company founded by Pascale Bouillé in 2005. Today, Vectalys counts 25 full-time employees exclusively dedicated to providing lentiviral vectors, cell models, molecular biology strategies and supporting your projects. Vectalys aims to help scientists worldwide understand cellular and molecular mechanisms in order to discover new drugs and therapies. Vectalys has developed a state-of-the-art proprietary technolo... gy to provide the highest quality of lentiviral vectors for the transduction of hard-to-transfect cells like primary cells, stem cells and in vivo tissues. Vectalys high quality lentiviral vectors ensure 100% transduction efficiency and non-toxic transduction on any target cells, for example to create predictive models. Because each project is unique, the Vectalys team supports you by providing custom lentiviral vectors for the right application with your gene of interest. Vectalys is also the manufacturer of highly pure ready-to-use lentiviral vectors carrying fluorescent, bioluminescent or gene editing proteins. These products are distributed worldwide. Vectalys is committed to providing solutions that save your time and support your most ambitious projects.

#SimilarOrganizations #People #Financial #Website #More

VECTALYS

Social Links:

Industry:
Biotechnology Manufacturing Wellness

Founded:
2005-01-01

Address:
Toulouse, Midi-Pyrenees, France

Country:
France

Website Url:
http://www.vectalys.com

Total Employee:
11+

Status:
Active

Total Funding:
5 M EUR

Technology used in webpage:
SPF IPv6 ShareThis Disqus Alwaysdata


Similar Organizations

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

innovent-biologics-logo

Innovent Biologics

Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.

microdermis-logo

Microdermis

Microdermis manufactures and markets skin care products for skin repair and protection, antimicrobial, and dental skin care.

passage-bio-logo

Passage Bio

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

slingshot-biosciences-logo

Slingshot Biosciences

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

Current Employees Featured

christine-duthoit_image

Christine Duthoit
Christine Duthoit Project Manager @ Vectalys
Project Manager
2018-05-01

Founder


pascale-bouillé_image

Pascale Bouillé

Investors List

auriga-partners_image

Auriga Partners

Auriga Partners investment in Venture Round - Vectalys

easme_image

EASME - EU Executive Agency for SMEs

EASME - EU Executive Agency for SMEs investment in Grant - Vectalys

wiseed_image

WiSEED

WiSEED investment in Venture Round - Vectalys

galia-gestion_image

Galia Gestion

Galia Gestion investment in Venture Round - Vectalys

ibrahim-soua_image

Ibrahim Soua

Ibrahim Soua investment in Seed Round - Vectalys

fadise_image

FaDièse

FaDièse investment in Series B - Vectalys

fadise_image

FaDièse

FaDièse investment in Series A - Vectalys

Official Site Inspections

http://www.vectalys.com

Unable to get host informations!!!

Loading ...

More informations about "Vectalys"

Vectalys - Crunchbase Company Profile & Funding

Vectalys, expert in gene delivery based on lentiviral vectors, is a private biotech company founded by Pascale Bouillé in 2005. Today, Vectalys counts 25 full-time employees exclusively …See details»

Vectalys - Products, Competitors, Financials, Employees, …

Vectalys is a private biotech company expert in gene delivery based on lentiviral and retroviral vectors. Vectalys use its own proprietary technology to provide highest quality vectors to …See details»

VECTALYS - VentureRadar

Vectalys is a gene delivery platform based on viral vector technologies. Vectalys’ platform is based on retroviral (RV), lentiviral (LV) and adeno-associated virus (AAV) based vectors that …See details»

Vectalys SAS - Company Profile and News - Bloomberg Markets

Vectalys SAS operates as a genomic platform based on viral vector technologies. It offers gene silencing, gene over-expression, cell-based assay development, protein expression and …See details»

New Gene Therapy Company To Focus On Lentiviral Platforms

May 18, 2018 · Biotech company Vectalys has merged with FlashCell, a developer of non-integrating lentiviral delivered RNA treatments, to form Flash Therapeutics, a new privately …See details»

Vectalys - Overview, News & Similar companies | ZoomInfo.com

Vectalys contact info: Phone number: +33 139046880 Website: www.vectalys.com What does Vectalys do? Vectalys SAS (Toulouse, France) is a biotechnology company that develops, …See details»

Vectalys - Contacts, Employees, Board Members, Advisors & Alumni

Vectalys help scientists understand cellular and molecular mechanisms in order to discover new drugs and therapies.See details»

Vectalys - Funding, Financials, Valuation & Investors - Crunchbase

Vectalys help scientists understand cellular and molecular mechanisms in order to discover new drugs and therapies.See details»

Vectalys | company | Mindmaps

Vectalys, expert in gene delivery based on lentiviral vectors, is a private biotech company founded by Pascale Bouillé in 2005. Today, Vectalys counts 25 full-time employees exclusively …See details»

Vectalys, FlashCell Merge to Form Gene Therapy Company

May 23, 2018 · LentiFlash technology delivers RNA into cells with high efficiency for short-term expression without integrating genetic material into the host cells’ genome, unlike conventional …See details»

VECTALYS AND FLASHCELL ANNOUNCE MERGER TO CREATE …

May 16, 2018 · Flash Therapeutics was established in 2018 through the merger of FlashCell, a privately held company developing LentiFlash®, based RNA therapeutics; and Vectalys, a …See details»

Vectalys and FlashCell Announce Merger to Create Flash …

May 16, 2018 · Flash Therapeutics will advance two complementary businesses: Worldwide contract development and manufacturing expertise and support - from discovery through GMP …See details»

Vectalys and FlashCell Announce Merger to Create Flash

May 16, 2018 · Vectalys, a leading biotech company specialized in manufacturing high quality lentiviral solutions for gene delivery, and FlashCell, a company developing non-integrating …See details»

Vectalys la société toulousaine de biotechnologie lance une levée …

Sep 10, 2012 · Vectalys, société innovante de biotechnologie spécialisée sur les vecteurs viraux et la transfection de gènes, annonce une recherche de fonds de 4M €, un nouvel accord de …See details»

Vectalys - Crunchbase

Vectalys help scientists understand cellular and molecular mechanisms in order to discover new drugs and therapies.See details»

Vectalys Company Information - Funding, Investors, and More

Get information on funding, investors, industries, and more for Vectalys. See Vectalys company profile and funding data.See details»

Vectalys | Biotech Careers

Gene Delivery, Services Business Areas: Cell and Gene TherapySee details»

Vectalys, FlashCell Merge to Form Gene Therapy Company

May 23, 2018 · The new company will develop proprietary RNA-based therapeutics and will provide broad lentiviral development and manufacturing expertise and support.See details»

Vectalys - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Vectalys help scientists understand cellular and molecular mechanisms in order to discover new drugs and therapies.See details»

Desktop Genetics, Vectalys and Horizon Discovery Collaborate

Sep 21, 2016 · Desktop Genetics Ltd has announced that it has entered into a collaboration agreement with Vectalys SAS and Horizon Discovery Group plc to design, produce and …See details»

linkstock.net © 2022. All rights reserved